ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,616Medicare Part D Prescriptions Filled, Including Refills

Rank: 283 out of 1692

$475K Total Retail Price of All Prescriptions

Rank: 270 out of 1692

691 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 691 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 691 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,844 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 438 411 1 1
AMLODIPINE BESYLATE 346 328 2 3
LEVOTHYROXINE SODIUM 275 232 3 4
LISINOPRIL 252 223 4 2
METFORMIN HCL 240 225 5 8
ATENOLOL 192 178 6 15
HYDROCODONE-ACETAMINOPHEN 185 165 S3 7 6
OMEPRAZOLE 183 167 8 5
FUROSEMIDE 148 141 9 7
GLIMEPIRIDE 142 132 10 32
ZOLPIDEM TARTRATE 137 128 11 23
CRESTOR 118 110 12 26
LOSARTAN POTASSIUM 115 115 13 17
HYDROCHLOROTHIAZIDE 112 98 14 9
LOSARTAN-HYDROCHLOROTHIAZIDE 108 107 15 38
DONEPEZIL HCL 106 106 16 29
PREDNISONE 106 87 16 35
METOPROLOL TARTRATE 104 93 18 10
DIOVAN 94 82 19 42
CITALOPRAM HBR 93 81 20 21
ATORVASTATIN CALCIUM 86 74 21 11
SERTRALINE HCL 86 55 21 22
PROAIR HFA 79 57 23 40
TRAMADOL HCL 76 59 24 16
POTASSIUM CHLORIDE 76 73 24 20
METOPROLOL SUCCINATE 72 56 26 18
INDAPAMIDE 68 68 27 180
WARFARIN SODIUM 64 60 28 14
AZITHROMYCIN 63 55 29 34
ALPRAZOLAM 63 61 29 188
SYNTHROID 62 61 31 59
LEVOXYL 61 60 32 170
GABAPENTIN 60 52 33 13
ESCITALOPRAM OXALATE 60 53 33 76
NEXIUM 60 48 33 25
PRAVASTATIN SODIUM 58 56 36 12
GLYBURIDE 56 56 R 37 82
CARVEDILOL 55 43 38 24
INSULIN SYRINGE 54 52 39 93
AMLODIPINE BESYLATE-BENAZEPRIL 54 54 39 67
ZETIA 51 51 41 68
CLONIDINE HCL 51 51 41 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 45 43 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.